Both in Pharmaceuticals

Apnimed vs Nuvectis Pharma

Over the past year APMD returned −41.3% and NVCT returned −20.1%; their daily moves had a correlation of 0.26.

APMD −41.3% NVCT −20.1%Growth of $1, one year, split-adjusted
MetricAPMDNVCT
Price$15.40$19.18
Market cap$641.1M$626.1M
Today−6.10%+3.79%
1 month−28.4%−12.5%
6 months—+115.7%
Year to date—+154.0%
1 year—+188.9%
Revenue growth (YoY)——
Gross margin——
Net margin——
P/E (TTM)——
Price / sales——
Net cash—$22.2M
Dividend yield——
Volatility (60d)—68.0%
Short % of float10.1%11.7%
Next earnings——

Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).

APMD vs NVCT: Apnimed vs Nuvectis Pharma Stock Comparison | Gainbot